Novartis
NVS
NVS
1,119 hedge funds and large institutions have $19.8B invested in Novartis in 2021 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 401 increasing their positions, 412 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8% less first-time investments, than exits
New positions opened: 73 | Existing positions closed: 79
1% less funds holding
Funds holding: 1,135 → 1,119 (-16)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
1,119
Holding in Top 10
3
Calls
$251M
Puts
$110M
Top Buyers
| 1 | +$254M | |
| 2 | +$173M | |
| 3 | +$143M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$40.1M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$27.8M |
Top Sellers
| 1 | -$133M | |
| 2 | -$128M | |
| 3 | -$115M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$84.1M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$68.4M |